131 related articles for article (PubMed ID: 1471200)
1. Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer.
Bartsch H; Castegnaro M; Rojas M; Camus AM; Alexandrov K; Lang M
Toxicol Lett; 1992 Dec; 64-65 Spec No():477-83. PubMed ID: 1471200
[TBL] [Abstract][Full Text] [Related]
2. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
3. Carcinogen metabolism and DNA adducts in human lung tissues as affected by tobacco smoking or metabolic phenotype: a case-control study on lung cancer patients.
Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Geneste O; Camoirano A; Saracci R; Giuntini C
Mutat Res; 1991; 250(1-2):103-14. PubMed ID: 1944327
[TBL] [Abstract][Full Text] [Related]
4. Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.
Bartsch H; Petruzzelli S; De Flora S; Hietanen E; Camus AM; Castegnaro M; Alexandrov K; Rojas M; Saracci R; Giuntini C
Environ Health Perspect; 1992 Nov; 98():119-24. PubMed ID: 1336722
[TBL] [Abstract][Full Text] [Related]
5. Metabolic polymorphism affecting DNA binding and excretion of carcinogens in humans.
Bartsch H; Rojas M; Alexandrov K; Camus AM; Castegnaro M; Malaveille C; Anttila S; Hirvonen K; Husgafvel-Pursiainen K; Hietanen E
Pharmacogenetics; 1995; 5 Spec No():S84-90. PubMed ID: 7581496
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients.
Petruzzelli S; Camus AM; Carrozzi L; Ghelarducci L; Rindi M; Menconi G; Angeletti CA; Ahotupa M; Hietanen E; Aitio A
Cancer Res; 1988 Aug; 48(16):4695-700. PubMed ID: 3135117
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pulmonary DNA adduct levels, measured by 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers.
Geneste O; Camus AM; Castegnaro M; Petruzzelli S; Macchiarini P; Angeletti CA; Giuntini C; Bartsch H
Carcinogenesis; 1991 Jul; 12(7):1301-5. PubMed ID: 2070496
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism of (-)-benzo[a]pyrene-7,8-diol by human lung microsomes and peripheral blood lymphocytes: effect of smoking.
Rojas M; Camus AM; Alexandrov K; Husgafvel-Pursiainen K; Anttila S; Vainio H; Bartsch H
Carcinogenesis; 1992 Jun; 13(6):929-33. PubMed ID: 1600613
[TBL] [Abstract][Full Text] [Related]
9. Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes.
Kiyohara C; Hirohata T
J Epidemiol; 1997 Dec; 7(4):244-50. PubMed ID: 9465551
[TBL] [Abstract][Full Text] [Related]
10. Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung: relation to single strand breaks of DNA.
Villard PH; Seree EM; Re JL; De Meo M; Barra Y; Attolini L; Dumenil G; Catalin J; Durand A; Lacarelle B
Toxicol Appl Pharmacol; 1998 Feb; 148(2):195-204. PubMed ID: 9473526
[TBL] [Abstract][Full Text] [Related]
11. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of pulmonary cytochrome P450IA and metabolic activities associated with P450IA1 and P450IA2 isozymes in lung cancer patients.
Anttila S; Vainio H; Hietanen E; Camus AM; Malaveille C; Brun G; Husgafvel-Pursiainen K; Heikkilä L; Karjalainen A; Bartsch H
Environ Health Perspect; 1992 Nov; 98():179-82. PubMed ID: 1336724
[TBL] [Abstract][Full Text] [Related]
13. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities.
Pasanen M; Haaparanta T; Sundin M; Sivonen P; Vakakangas K; Raunio H; Hines R; Gustafsson JA; Pelkonen O
Toxicology; 1990 May; 62(2):175-87. PubMed ID: 1693794
[TBL] [Abstract][Full Text] [Related]
15. Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer.
Nakajima T; Elovaara E; Anttila S; Hirvonen A; Camus AM; Hayes JD; Ketterer B; Vainio H
Carcinogenesis; 1995 Apr; 16(4):707-11. PubMed ID: 7728947
[TBL] [Abstract][Full Text] [Related]
16. The effect of cigarette smoke on aryl hydrocarbon hydroxylase activity and cytochrome P450 content in rat liver and lung microsomes.
Kushinsky R; Louis CJ
Oncology; 1976; 33(5-6):197-200. PubMed ID: 1026852
[TBL] [Abstract][Full Text] [Related]
17. Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking.
Anttila S; Hakkola J; Tuominen P; Elovaara E; Husgafvel-Pursiainen K; Karjalainen A; Hirvonen A; Nurminen T
Cancer Res; 2003 Dec; 63(24):8623-8. PubMed ID: 14695173
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts.
Mollerup S; Berge G; Baera R; Skaug V; Hewer A; Phillips DH; Stangeland L; Haugen A
Int J Cancer; 2006 Aug; 119(4):741-4. PubMed ID: 16557573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
